Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05812989 · ClinicalTrials.gov registry record · NA

Modifiers and Mechanisms of Loneliness Interventions

A NA study, sponsored by University of Rochester.

Completed
Registry status
NA
Development phase
53
Enrollment target

NCT05812989: Completed NA study, sponsored by University of Rochester.

NCT05812989 is a NA study that has completed, run by University of Rochester. The registered enrollment target is 53 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05812989, a NA study, has completed, sponsored by University of Rochester.

COMPLETED
Registry status
NA
Development phase
53 participants
Enrollment target

Study Summary

A specific aim of this research is to identify the role of emotion regulation in response to social threat in caregivers' response to a behavioral coaching intervention for loneliness. A second aim of the study is to determine the benefit of a digitized, social engagement prioritization tool for improving coaches' intervention fidelity and caregiver outcomes. This study is funded through the Pilot Award Program of the Rochester Roybal Center for Social Ties \& Aging Research, a UR Center funded by the National Institute on Aging by grant P30AG064103.

Primary Outcome

UCLA Loneliness Scale Version 3, which assesses self-reported loneliness. 20 items, rated as to how often the participant has felt a certain way in the prior month (e.g., "How often do you feel alone?") -- "never" (1), "rarely" (2), "sometimes" (3), or "often" (4). Higher scores indicate greater loneliness. However, some individual items must be reverse-coded so that higher total scores reflect greater loneliness (i.e., 1=4, 2=3, 3=2, 4=1). These items (e.g., "How often do you feel there are peo

Interventions

  • BEHAVIORAL Connect for Caregivers
  • BEHAVIORAL Social Engage Coaching

Trial Details

FieldValue
Enrollment Target 53 participants
Start Date 2023-10-18
Est. Completion 2025-05-30
Phase NA
University of Rochester

636 total trials

What the finished NCT05812989 record still lists

NCT05812989 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 53 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).

The record links to 0 conditions, and to 2 interventions - of which Connect for Caregivers is the first listed.

NCT05812989 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05812989 about?

NCT05812989 is a clinical study titled "Modifiers and Mechanisms of Loneliness Interventions". A specific aim of this research is to identify the role of emotion regulation in response to social threat in caregivers' response to a behavioral coaching intervention for loneliness. A second aim of the study is to determine the benefit of a digitized, social engagement prioritization tool for imp...

What is the current status of trial NCT05812989?

This trial is currently completed. It is a NA study. The enrollment target is 53 participants. The study started on 2023-10-18. Estimated completion is 2025-05-30.

What interventions are being tested in trial NCT05812989?

The interventions under investigation include: Connect for Caregivers (BEHAVIORAL), Social Engage Coaching (BEHAVIORAL).

Who is sponsoring clinical trial NCT05812989?

This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05812989's enrollment target sits among peer trials

53 1271st of 2000 higher than 729 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04177004 · 53 participants · Phase 1

    Human Lysozyme Goat Milk for the Prevention of Graft Versus Host Disease in Patients With Blood Cancer Undergoing a Donor Stem Cell Transplant

  • NCT04199741 · 53 participants · Phase 1

    PET/CT Imaging of Small Cell Lung Cancer Using 89Zr-DFO-SC16.56

  • NCT04835129 · 53 participants · Phase 2

    Isatuximab, Pomalidomide, Elotuzumab and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma

  • NCT04913805 · 53 participants · Phase 2

    Matching Perfusion and Metabolic Activity in HFpEF

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05812989, the US trial registry maintained by the National Library of Medicine. NCT05812989 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.